Growth hormone response to insulin and to arginine in patients with familial hypercholesterolaemia.
Human growth hormone (HGH) response to i.v. insulin (0.1 U/kg body weight) and arginine infusion (25 g of L-arginine for 30 min) was studied in 9 patients (5 males and 4 females) with primary familial hypercholesterolaemia and belonging to 4 families. Mean age was 28 +/- 2 years (range 18-36) and body weight was less than 105% of ideal body weight. Glucose tolerance and insulin response to oral glucose were normal in all patients. HGH release after insulin and after arginine was slightly increased as compared to 21 normal controls, but the differences were not significant. Insulin and glucagon response to arginine in these patients was within the normal range. Plasma glucose and free fatty acids were normal after both insulin and arginine. Moreover, no significant correlation was found between fasting cholesterol and HGH peaks after insulin and after arginine, nor between cholesterol and insulin and glucagon responses. Despite marked hyperlipidaemia, HGH-deficient patients examined by other authors never present signs of atherosclerotic disease. Our data suggest that HGH, in the presence of elevated cholesterol levels, might play an important role in the development of atherosclerotic lesions.
D000293:Adolescent; D000328:Adult; D001120:Arginine / Q000008:administration & dosage / Q000494:pharmacology*; D004334:Drug Administration Schedule; D004392:Dwarfism / Q000150:complications; D005260:Female; D005934:Glucagon / Q000378:metabolism; D013006:Growth Hormone / Q000378:metabolism*; D006801:Humans; D006937:Hypercholesterolemia / Q000235:genetics*; D007328:Insulin / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D000078790:Insulin Secretion; D008297:Male
D007328:Insulin; D013006:Growth Hormone; D005934:Glucagon; D001120:Arginine